GILD

Gilead Sciences, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$167.95

Price (1 Year)

$170.68 $120.4

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %20.3 / %30
Non-compliant assets / Total market cap %4.2 / %30
Non-compliant revenue / Total income %0.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients.

Website

Analysis (Turkish): GILD Hissesi Caiz mi, Helal mi? Gilead Sciences, Inc. Katılım Analizi